# AIPher Raises RMB 100M in Angel Round

On September 3, 2026, Beijing-based AIPher, an AI-native drug developer, raised RMB 100 million in an Angel round led by Xianghe Capital. Gao Bowen serves as CEO, Lan Yanyan as chief scientist and Zhang Yaqin as chief scientific advisor.



Canonical: https://uniquebase.ai/news/3984b6b2-f2a0-4d24-baf8-90a1ca2f400b
Stable identifier: 3984b6b2-f2a0-4d24-baf8-90a1ca2f400b
Snapshot captured: 2026-10-20T18:19:32.670Z
English updated: 2026-10-20T18:21:32.462Z

## Connected profiles

- [Aifeizhiyao](/companies/UB-C9363)
- [Xianghe Capital](/institutions/xianghe-capital)

## Sources

- https://www.cnr.cn/mspd/sywzl/20260903/t20260903_527803600.shtml